SPIRO DERIVATIVES AND ADHESION MOLECULE INHIBITORS COMPRISING THE SAME AS THE ACTIVE INGREDIENT
申请人:TORAY INDUSTRIES, INC.
公开号:EP1489081A1
公开(公告)日:2004-12-22
Disclosed is the use of an adhesion molecule inhibitor that is effective in the prevention and treatment of inflammatory diseases caused by infiltration of leukocytes such as monocytes, lymphocytes and eosinophils, by inhibiting cell infiltration which mediates adhesion molecules, especially adhesion molecule VLA-4.
Since the spiro acid derivatives according to the present invention are excellent in the effect of inhibiting cell adhesion via adhesion molecules, especially adhesion molecule VLA-4, they are useful as therapeutic drugs against various inflammatory diseases. For example, provided are the spiro derivative and the adhesion molecule inhibitor which includes as an active ingredient the spiro derivative as shown by the below formula (18).
本发明公开了一种粘附分子抑制剂,通过抑制介导粘附分子(尤其是粘附分子 VLA-4)的细胞浸润,可有效预防和治疗由单核细胞、淋巴细胞和嗜酸性粒细胞等白细胞浸润引起的炎症性疾病。
由于本发明的螺酸衍生物在抑制细胞通过粘附分子(尤其是粘附分子 VLA-4)的粘附方面具有出色的效果,因此可作为治疗药物用于各种炎症性疾病。例如,本发明提供了螺衍生物和粘附分子抑制剂,其活性成分包括如下式(18)所示的螺衍生物。